Inovio drops appeal of injunction ruling in court battle over experimental Covid-19 vaccine

Inovio has set a goal of producing 1 million doses of its DNA-based Covid-19 vaccine by the end of this year and 100 million doses by the end of 2021.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.